Certified by Founder Lodge
SV Health Investors
United Kingdom - London, London
INVESTOR
1 Disclosed Funding Rounds $125,000,000
35 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth, heal
| Company | Date | Round | Raised |
|---|---|---|---|
 EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
 Miach Orthopaedics, Inc. |
April, 04 ,2024 | Series B | $20,000,000 |
 SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
 Nimbus Therapeutics |
September, 13 ,2022 | Unknown | $125,000,000 |
 Therini Bio, Inc. |
April, 27 ,2023 | Series A | $36,000,000 |
 Harness Therapeutics |
December, 01 ,2023 | Unknown | $5,067,000 |
 Brixton Biosciences |
May, 15 ,2024 | Series B | $33,000,000 |
 LoQus23 Therapeutics Ltd |
October, 02 ,2024 | Series A | $46,550,175 |
 Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
| Miach Orthopaedics, Inc. |
April, 04 ,2024 | Series B | $20,000,000 |
 Spineology Inc. |
August, 07 ,2024 | Unknown | $25,000,000 |
 Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
| EyeBio |
November, 15 ,2023 | Series A | $65,000,000 |
| Brixton Biosciences |
May, 15 ,2024 | Series B | $33,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Harness Therapeutics |
December, 01 ,2023 | Unknown | $5,067,000 |
| Spineology Inc. |
August, 07 ,2024 | Unknown | $25,000,000 |
| LoQus23 Therapeutics Ltd |
October, 02 ,2024 | Series A | $46,550,175 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Miach Orthopaedics, Inc. |
April, 04 ,2024 | Series B | $20,000,000 |
| LoQus23 Therapeutics Ltd |
October, 02 ,2024 | Series A | $46,550,175 |
| Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
| Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
| Brixton Biosciences |
May, 15 ,2024 | Series B | $33,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
 TRIMTECH Therapeutics Limited |
March, 07 ,2025 | Seed | $31,000,000 |
| Spineology Inc. |
August, 07 ,2024 | Unknown | $25,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| LoQus23 Therapeutics Ltd |
October, 02 ,2024 | Series A | $46,550,175 |
| Enara Bio |
October, 04 ,2024 | Series B | $32,500,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| TRIMTECH Therapeutics Limited |
March, 07 ,2025 | Seed | $31,000,000 |
 Alchemab Therapeutics Ltd |
September, 10 ,2025 | Series A |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
